CLOVClover Health Investments, Corp.

$4.25

$1.7052 weeks$5.21

Price

$4.25+92%1Y

1M-6.5%1Y+92%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

10/10

Value97

Quality64

Momentum83

Growth86

Strongest Value, weakest Quality · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

(1)Represents full year 2025 Benefits expense ratio (“BER”) for Clover Health, as well as most recent results of other public companies with “Traditional MA Plan” approaches that have reported results as of the time of this publication. BER is a non-GAAP financial measure. We calculate our BER by taking the total of Insurance net medical expenses incurred and quality improvements, and dividing that total by premiums earned on a net basis, in a given period.

In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$2.63B

1Y Return+92%

5Y Return-48%

Business segments

Q2 2025 · $32.4M

The company’s own SEC segment disclosure.

Insurance$16.2M50%
Insurance$16.2M50%

Clover Health Investments, Corp. (CLOV) reported revenue of $743M in Q2 2026 (quarter ended June 30, 2026), up 56% from the same quarter a year earlier. That came with net income of $28M (3.8% of revenue). For the full year FY2025, revenue was $1.92B (+40% year on year) and net income −$86M. Its largest segment in 2025-Q2 was Insurance at $16M, 50.0% of the disclosed total, just ahead of Insurance at 50.0%.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.

Healthcare Plans

Ranks #2 of 11 by Smart Score

Alignment Healthcare, Inc.

OSCR-1.7%

Oscar Health, Inc.

MOH+7.3%

Molina Healthcare, Inc.